STOCK TITAN

[144] PTC THERAPEUTICS, INC. SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

PTCT submitted a Form 144 reporting a proposed sale of 3,056 common shares tied to restricted stock vesting on 02/17/2026. The filing also lists recent open-market sales by insiders, including Neil G. Almstead (examples shown: 35,572 shares on 11/24/2025 and 71,928 shares on 11/25/2025). The transactions are presented as issuer compensation and past sales over the prior three months.

Positive

  • None.

Negative

  • None.

Insights

Form 144 records a proposed sale of 3,056 vested restricted shares and multiple recent insider disposals.

The filing lists a proposed sale of 3,056 common shares associated with restricted stock vesting on 02/17/2026. It also enumerates several prior sales by Neil G. Almstead and Zheng Y. Almstead during the past three months with specific dates and share counts.

Timing and cash‑flow treatment are the filing's focus; transaction execution details depend on broker and market mechanics. Subsequent SEC reports or Forms 4 may show final sale amounts and net proceeds.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature